Pharmacy Focus
Pharmacy Times
Add to My Podcasts
Episodes
About
Reviews
Promote
S2 Ep92: Beyond CRS and ICANS: Managing the Delayed Toxicities of Cilta-cel
50 minutes
Posted Aug 28, 2026 at 10:00 am.
0:00
50:56
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Sara Scott, PharmD, BCOP, Emma Uchida, PharmD, MBA, BCOP, and Rebecca Gonzalez, PharmD, BCOP, gather for a roundtable on the rare, delayed toxicities associated with ciltacabtagene autoleucel in relapsed/refractory multiple myeloma.
Previous
S2 Ep91: Food, Fungals, and Flexibility: Real-World Dosing of Revumenib
Next
S2 Ep93: Vaccine Timing and Safety in Patients With Neurological Diseases
← See all 357 episodes of Pharmacy Focus
